Leopoldo Luistro

Title: The Innovations of Leopoldo Luistro

Introduction

Leopoldo Luistro is an accomplished inventor based in Spring House, PA (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of bispecific binding agents.

Latest Patents

Luistro holds a patent for "Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof." This patent describes isolated CD3×PSMA-bispecific antigen-binding molecules, which include a FN3 domain that specifically binds to human prostate specific membrane antigen (PSMA) and a second antigen-binding site that immunospecifically binds to CD3. The patent also covers fusion proteins, related polynucleotides capable of encoding these fusion proteins, and cells that express the provided fusion proteins. Additionally, it outlines methods for using these isolated bispecific antigen-binding molecules.

Career Highlights

Luistro is currently associated with Janssen Biotech, Inc., where he continues to innovate in the field of cancer treatment. His work focuses on developing advanced therapeutic agents that can improve patient outcomes.

Collaborations

He has collaborated with notable colleagues, including Glenn Mark Anderson and Rosa Cardoso, to further enhance the research and development of bispecific binding agents.

Conclusion

Leopoldo Luistro's contributions to the field of biomedical engineering, particularly through his innovative patent, demonstrate his commitment to advancing cancer therapies. His work at Janssen Biotech, Inc. and collaborations with esteemed colleagues highlight the importance of teamwork in scientific advancements.